skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Structure of Neuroblastoma Suppressor of Tumorigenicity 1 (NBL1): Insights for the Functional Variability across Bone Morphogenetic Protein (BMP) Antagonists

Authors:
; ; ; ; ; ; ;  [1]
  1. (UCIN)
Publication Date:
Research Org.:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Org.:
NIHAHA
OSTI Identifier:
1171862
Resource Type:
Journal Article
Resource Relation:
Journal Name: J. Biol. Chem.; Journal Volume: 290; Journal Issue: (8) ; 02, 2015
Country of Publication:
United States
Language:
ENGLISH

Citation Formats

Nolan, Kristof, Kattamuri, Chandramohan, Luedeke, David M., Angerman, Elizabeth B., Rankin, Scott A., Stevens, Mariana L., Zorn, Aaron M., and Thompson, Thomas B. Structure of Neuroblastoma Suppressor of Tumorigenicity 1 (NBL1): Insights for the Functional Variability across Bone Morphogenetic Protein (BMP) Antagonists. United States: N. p., 2016. Web. doi:10.1074/jbc.M114.628412.
Nolan, Kristof, Kattamuri, Chandramohan, Luedeke, David M., Angerman, Elizabeth B., Rankin, Scott A., Stevens, Mariana L., Zorn, Aaron M., & Thompson, Thomas B. Structure of Neuroblastoma Suppressor of Tumorigenicity 1 (NBL1): Insights for the Functional Variability across Bone Morphogenetic Protein (BMP) Antagonists. United States. doi:10.1074/jbc.M114.628412.
Nolan, Kristof, Kattamuri, Chandramohan, Luedeke, David M., Angerman, Elizabeth B., Rankin, Scott A., Stevens, Mariana L., Zorn, Aaron M., and Thompson, Thomas B. 2016. "Structure of Neuroblastoma Suppressor of Tumorigenicity 1 (NBL1): Insights for the Functional Variability across Bone Morphogenetic Protein (BMP) Antagonists". United States. doi:10.1074/jbc.M114.628412.
@article{osti_1171862,
title = {Structure of Neuroblastoma Suppressor of Tumorigenicity 1 (NBL1): Insights for the Functional Variability across Bone Morphogenetic Protein (BMP) Antagonists},
author = {Nolan, Kristof and Kattamuri, Chandramohan and Luedeke, David M. and Angerman, Elizabeth B. and Rankin, Scott A. and Stevens, Mariana L. and Zorn, Aaron M. and Thompson, Thomas B.},
abstractNote = {},
doi = {10.1074/jbc.M114.628412},
journal = {J. Biol. Chem.},
number = (8) ; 02, 2015,
volume = 290,
place = {United States},
year = 2016,
month = 8
}
  • A calmodulin (CaM)-like protein (hCLP) is expressed in human mammary epithelial cells but appears to be limited to certain epithelial cells such as those found in skin, prostate, breast and cervical tissues. A decrease in the expression of this protein is associated with the occurrence of tumors in breast epithelium. The structure of hCLP determined to 1.5 Å resolution by X-ray crystallography shows a distinct 30° displacement along the interconnecting central helix, when compared to the highly conserved structure of vertebrate CaM, resulting in a difference in the relative orientation of its two globular domains. Additionally, the electric surface potentialmore » landscape at the target protein binding regions on the two globular domains of hCLP is significantly different from those of CaM, indicating that the respective ranges of hCLP and hCaM target proteins do not fully overlap. Observations that hCLP can competitively inhibit CaM activation of target proteins also imply a role for hCLP in which it may also serve as a modulator of CaM activity in the epithelial cells where hCLP is expressed.« less
  • The in vivo bone response of 3D periodic hydroxyapatite (HA) scaffolds is investigated. Two groups of HA scaffolds (11 mm diameter x 3.5 mm thick) are fabricated by direct-write assembly of a concentrated HA ink. The scaffolds consist of cylindrical rods periodically arranged into four quadrants with varying separation distances between rods. In the first group, HA rods (250 {micro}m in diameter) are patterned to create pore channels, whose areal dimensions are 250 x 250 {micro}m{sup 2} in quadrant 1, 250 x 500 {micro}m{sup 2} in quadrants 2 and 4, and 500 x 500 {micro}m{sup 2} in quadrant 3. Inmore » the second group, HA rods (400 {micro}m in diameter) are patterned to create pore channels, whose areal dimensions of 500 x 500 {micro}m{sup 2} in quadrant 1, 500 x 750 {micro}m{sup 2} in quadrants 2 and 4, and 750 x 750 {micro}m{sup 2} in quadrant 3. Each group of scaffolds is partially densified by sintering at 1200 C prior to being implanted bilaterally in trephine defects of skeletally mature New Zealand White rabbits. Their tissue response is evaluated at 8 and 16 weeks using micro-computed tomography, histology, and scanning electron microscopy. New trabecular bone is conducted rapidly and efficiently across substantial distances within these patterned 3D HA scaffolds. Our observations suggest that HA rods are first coated with a layer of new bone followed by subsequent scaffold infilling via outward and inward radial growth of the coated regions. Direct-write assembly of 3D periodic scaffolds composed of micro-porous HA rods arrayed to produce macro-pores that are size-matched to trabecular bone may represent an optimal strategy for bone repair and replacement structures.« less
  • Bone morphogenetic protein (BMP), a paracrine agent inducing cartilage and bone cell differentiation, circulates in the blood and is detectable by BMP radioimmunoassay. Serum BMP levels are higher in growing children and patients with Paget's disease than in normal adults. These observations are interpreted as evidence of a BMP function in the physiology of bone in health and disease.